Risk factors for loss of residual renal function in children treated with chronic peritoneal dialysis

Imagem de Miniatura
Arquivos
art_HA_Risk_factors_for_loss_of_residual_renal_function_2015.PDF (515.48 KB)
Citações na Scopus
35
Tipo de produção
article
Data de publicação
2015
Editora
ELSEVIER SCIENCE INC
DOI
Indexadores
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Autores
HA, Il-Soo
YAP, Hui K.
MUNARRIZ, Reyner L.
ZAMBRANO, Pedro H.
FLYNN, Joseph T.
BILGE, Ilmay
SZCZEPANSKA, Maria
LAI, Wai-Ming
ANTONIO, Zenaida L.
GULATI, Ashima
Autor de Grupo de pesquisa
Int Pediatric Peritoneal Dialysis
Editores
Coordenadores
Organizadores
Citação
KIDNEY INTERNATIONAL, v.88, n.3, p.605-613, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
In dialyzed patients, preservation of residual renal function is associated with better survival, lower morbidity, and greater quality of life. To analyze the evolution of residual diuresis over time, we prospectively monitored urine output in 401 pediatric patients in the global IPPN registry who commenced peritoneal dialysis (PD) with significant residual renal function. Associations of patient characteristics and time-variant covariates with daily urine output and the risk of developing oligoanuria (under 100 ml/m(2)/day) were analyzed by mixed linear modeling and Cox regression analysis including time-varying covariates. With an average loss of daily urine volume of 130 ml/m(2) per year, median time to oligoanuria was 48 months. Residual diuresis significantly subsided more rapidly in children with glomerulopathies, lower diuresis at start of PD, high ultrafiltration volume, and icodextrin use. Administration of diuretics significantly reduced oligoanuria risk, whereas the prescription of renin-angiotensin system antagonists significantly increased the risk oligoanuria. Urine output on PD was significantly associated in a negative manner with glomerulopathies (-584 ml/m(2)) and marginally with the use of icodextrin (-179 ml/m(2)) but positively associated with the use of biocompatible PD fluid (+111 ml/m(2)). Children in both Asia and North America had consistently lower urine output compared with those in Europe perhaps due to regional variances in therapy. Thus, in children undergoing PD, residual renal function depends strongly on the cause of underlying kidney disease and may be modifiable by diuretic therapy, peritoneal ultrafiltration, and choice of PD fluid.
Palavras-chave
children, oligoanuria, peritoneal dialysis, registry, risk factors, urine volume
URI
https://observatorio.fm.usp.br/handle/OPI/33272
Referências
  1. Bakkaloglu SA, 2009, NEPHROL DIAL TRANSPL, V24, P3525, DOI 10.1093/ndt/gfp297
  2. Bernardo Ana, 2009, Adv Perit Dial, V25, P110
  3. Borzych-Duzalka D, 2013, J AM SOC NEPHROL, V24, P665, DOI 10.1681/ASN.2012050433
  4. Bragg-Gresham JL, 2007, AM J KIDNEY DIS, V49, P426, DOI 10.1053/j.ajkd.2006.12.012
  5. Caravaca F, 2002, PERITON DIALYSIS INT, V22, P414
  6. Chadha V, 2001, PERITON DIALYSIS INT, V21, pS179
  7. Cho Y, 2014, COCHRANE DB SYST REV, V3
  8. Cho Y, 2013, KIDNEY INT, V84, P969, DOI 10.1038/ki.2013.190
  9. Coronel F, 2007, PERITON DIALYSIS INT, V27, P454
  10. Drechsler C, 2009, AM J KIDNEY DIS, V53, P1014, DOI 10.1053/j.ajkd.2008.11.027
  11. Fan SLS, 2008, KIDNEY INT, V73, P200, DOI 10.1038/sj.ki.5002574
  12. FEBER J, 1994, PEDIATR NEPHROL, V8, P579, DOI 10.1007/BF00858132
  13. Guzzo I, 2009, PEDIATR NEPHROL, V24, P1391, DOI 10.1007/s00467-009-1144-7
  14. Haag-Weber M, 2010, NEPHROL DIAL TRANSPL, V25, P2288, DOI 10.1093/ndt/gfq087
  15. Harambat J, 2013, AM J TRANSPLANT, V13, P2066, DOI 10.1111/ajt.12288
  16. Herget-Rosenthal S, 2012, KIDNEY BLOOD PRESS R, V35, P233, DOI 10.1159/000332887
  17. Hidaka H, 2003, NEPHROLOGY, V8, P184, DOI 10.1046/j.1440-1797.2003.00156.x
  18. Hiroshige K, 1996, PERITON DIALYSIS INT, V16, P307
  19. Hufnagel C, 1999, NEPHROL DIAL TRANSPL, V14, P1224, DOI 10.1093/ndt/14.5.1224
  20. Jafar TH, 2003, ANN INTERN MED, V139, P244, DOI 10.7326/0003-4819-139-4-200308190-00006
  21. Johnson DW, 2012, J AM SOC NEPHROL, V23, P1097, DOI 10.1681/ASN.2011121201
  22. Johnson DW, 2003, PERITON DIALYSIS INT, V23, P276
  23. Kim S, 2009, NEPHROL DIAL TRANSPL, V24, P2899, DOI 10.1093/ndt/gfp054
  24. Lang SM, 2001, PERITON DIALYSIS INT, V21, P52
  25. Liao CT, 2008, PERITON DIALYSIS INT, V28, pS191
  26. Liao CT, 2009, NEPHROL DIAL TRANSPL, V24, P2909, DOI 10.1093/ndt/gfp056
  27. Lui SL, 2012, AM J KIDNEY DIS, V60, P966, DOI 10.1053/j.ajkd.2012.05.018
  28. Lysaght M J, 1991, ASAIO Trans, V37, P598
  29. Marron B, 2008, KIDNEY INT, V73, pS42, DOI 10.1038/sj.ki.5002600
  30. Medcalf JF, 2001, KIDNEY INT, V59, P1128, DOI 10.1046/j.1523-1755.2001.00598.x
  31. Michels WM, 2011, CLIN J AM SOC NEPHRO, V6, P537, DOI 10.2215/CJN.00470110
  32. Misra M, 2001, KIDNEY INT, V59, P754, DOI 10.1046/j.1523-1755.2001.059002754.x
  33. Moist LM, 2000, J AM SOC NEPHROL, V11, P556
  34. Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555
  35. Perl J, 2009, AM J KIDNEY DIS, V53, P1068, DOI 10.1053/j.ajkd.2009.02.012
  36. Shemin D, 2000, PERITON DIALYSIS INT, V20, P439
  37. Shin SK, 1999, PERITON DIALYSIS INT, V19, P138
  38. Singhal MK, 2000, PERITON DIALYSIS INT, V20, P429
  39. Takatori Y, 2011, CLIN J AM SOC NEPHRO, V6, P1337, DOI 10.2215/CJN.10041110
  40. VANOLDEN RW, 1992, AM J NEPHROL, V12, P351, DOI 10.1159/000168471
  41. Wang AYM, 2006, KIDNEY INT, V69, P1726, DOI 10.1038/sj.ki.5000382
  42. Wuhl E, 2009, NEW ENGL J MED, V361, P1639, DOI 10.1056/NEJMoa0902066

Coleções
Artigos e Materiais de Revistas Científicas - HC/ICr
Artigos e Materiais de Revistas Científicas - LIM/36
Artigos e Materiais de Revistas Científicas - ODS/03